Income Statement Balance Sheet Cash Flow Statement
Annual Financials for United Therapeutics Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 369.85M 603.83M 743.18M 914.08M 1.12B
Cost of Goods Sold (COGS) incl. D&A 45.32M 73.47M 88.9M 119.3M 131.13M
COGS excluding D&A 33.93M 55.55M 68.37M 92.15M 99.87M
Depreciation & Amortization Expense 11.39M 17.92M 20.54M 27.15M 31.26M
Depreciation 10.68M 16.32M 18.2M 25M 28.66M
Amortization of Intangibles 717,000 1.6M 2.34M 2.15M 2.6M
Gross Income 324.53M 530.37M 654.28M 794.78M 985.86M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 294.33M 360.16M 344.21M 368.33M 693.36M
Research & Development 122.19M 166.76M 180.02M 173.39M 299.35M
Other SG&A 172.14M 193.4M 164.19M 194.95M 394.01M
Other Operating Expense 0 0 0 0 0
Unusual Expense 5.14M 11.7M 0 (26.2M) (210,000)
EBIT after Unusual Expense (5.14M) (11.7M) 0 26.2M 210,000
Non Operating Income/Expense 1.58M 6.27M 7.08M 866,000 425,000
Non-Operating Interest Income 5.15M 2.94M 3.45M 3.94M 3.83M
Equity in Affiliates (Pretax) (141,000) (160,000) (119,000) (143,000) 0
Interest Expense 12.88M 19.71M 21.37M 16.64M 18.06M
Gross Interest Expense 12.88M 19.61M 22.21M 17.54M 18.12M
Interest Capitalized 0 (103,000) 842,000 905,000 59,000
Pretax Income 18.77M 147.84M 299.12M 440.67M 278.9M
Income Tax (695,000) 41.92M 81.87M 136.23M 104.34M
Income Tax - Current Domestic 16.3M 28.18M 71.89M 98.54M 150.01M
Income Tax - Current Foreign 158,000 846,000 544,000 659,000 2.16M
Income Tax - Deferred Domestic (17.16M) 14.19M 8.8M 36.84M (46.77M)
Income Tax - Deferred Foreign 0 (1.29M) 641,000 182,000 (1.06M)
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income 19.46M 105.92M 217.24M 304.44M 174.56M
Minority Interest Expense 0 0 0 0 0
Net Income 19.46M 105.92M 217.24M 304.44M 174.56M
Extraordinaries & Discontinued Operations 0 0 625,000 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 618,000 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 7,000 0 0
Net Income After Extraordinaries 19.46M 105.92M 217.87M 304.44M 174.56M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 19.46M 105.92M 217.24M 304.44M 174.56M
EPS (Basic) 0.37 1.89 3.80 5.84 3.49
Basic Shares Outstanding 53.31M 56.14M 57.16M 52.09M 50.08M
EPS (Diluted) 0.35 1.78 3.66 5.71 3.28
Diluted Shares Outstanding 56.13M 59.52M 59.4M 53.28M 53.23M
EBITDA 41.6M 188.13M 330.61M 453.59M 323.76M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.